Cumberland Interest Income from 2010 to 2024

CPIX Stock  USD 2.44  1.20  96.77%   
Cumberland Pharmaceuticals Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income will likely drop to about 168.8 K in 2024. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals
 
Interest Income  
First Reported
2019-03-31
Previous Quarter
61.8 K
Current Value
69.2 K
Quarterly Volatility
34.8 K
 
Covid
Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 701.3 K or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 0.82. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Interest Income Growth Pattern

Below is the plot of the Interest Income of Cumberland Pharmaceuticals over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Cumberland Pharmaceuticals' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Interest Income10 Years Trend
Very volatile
   Interest Income   
       Timeline  

Cumberland Interest Income Regression Statistics

Arithmetic Mean182,926
Geometric Mean149,682
Coefficient Of Variation69.32
Mean Deviation86,500
Median135,320
Standard Deviation126,797
Sample Variance16.1B
Range538.4K
R-Value0.09
Mean Square Error17.2B
R-Squared0.01
Significance0.75
Slope2,521
Total Sum of Squares225.1B

Cumberland Interest Income History

2024168.8 K
2023251.6 K
202298.4 K
202126.1 K
202075.3 K
2019243.4 K
2018564.5 K

Other Fundumenentals of Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Interest Income component correlations

0.640.87-0.230.390.330.490.430.750.190.660.40.760.22-0.310.270.10.02-0.15-0.01
0.640.53-0.820.85-0.38-0.18-0.420.940.3-0.05-0.410.91-0.30.45-0.540.050.490.510.25
0.870.53-0.10.140.50.510.40.60.110.570.320.680.23-0.470.250.19-0.36-0.39-0.36
-0.23-0.82-0.1-0.850.740.40.7-0.74-0.360.480.64-0.750.52-0.810.730.0-0.65-0.8-0.55
0.390.850.14-0.85-0.63-0.35-0.540.740.43-0.13-0.520.72-0.440.69-0.640.00.810.830.69
0.33-0.380.50.74-0.630.730.84-0.230.00.710.79-0.250.58-0.950.820.33-0.71-0.87-0.65
0.49-0.180.510.4-0.350.730.79-0.020.10.680.70.080.53-0.720.630.16-0.54-0.63-0.3
0.43-0.420.40.7-0.540.840.79-0.22-0.130.840.96-0.170.62-0.890.950.06-0.55-0.79-0.31
0.750.940.6-0.740.74-0.23-0.02-0.220.30.05-0.170.91-0.290.32-0.310.10.430.380.21
0.190.30.11-0.360.430.00.1-0.130.30.05-0.090.2-0.190.18-0.160.830.370.410.32
0.66-0.050.570.48-0.130.710.680.840.050.050.750.090.47-0.770.680.11-0.28-0.53-0.16
0.4-0.410.320.64-0.520.790.70.96-0.17-0.090.75-0.190.6-0.820.970.1-0.44-0.72-0.28
0.760.910.68-0.750.72-0.250.08-0.170.910.20.09-0.19-0.170.28-0.31-0.070.280.320.26
0.22-0.30.230.52-0.440.580.530.62-0.29-0.190.470.6-0.17-0.590.61-0.09-0.4-0.63-0.36
-0.310.45-0.47-0.810.69-0.95-0.72-0.890.320.18-0.77-0.820.28-0.59-0.84-0.170.780.930.66
0.27-0.540.250.73-0.640.820.630.95-0.31-0.160.680.97-0.310.61-0.840.07-0.53-0.79-0.33
0.10.050.190.00.00.330.160.060.10.830.110.1-0.07-0.09-0.170.07-0.020.01-0.18
0.020.49-0.36-0.650.81-0.71-0.54-0.550.430.37-0.28-0.440.28-0.40.78-0.53-0.020.890.78
-0.150.51-0.39-0.80.83-0.87-0.63-0.790.380.41-0.53-0.720.32-0.630.93-0.790.010.890.78
-0.010.25-0.36-0.550.69-0.65-0.3-0.310.210.32-0.16-0.280.26-0.360.66-0.33-0.180.780.78
Click cells to compare fundamentals

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Income251.6 K168.8 K
Net Interest Income-417 K-396.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.